New ‘safer opioid’ delivers pain relief without addiction risk in early tests

New ‘safer opioid’ delivers pain relief without addiction risk in early tests

The drug, DFNZ, still needs human clinical trials before it could reach patients, experts caution...

Redirecting to full article...